Please login to the form below

Not currently logged in
Email:
Password:

cell and gene therapies

This page shows the latest cell and gene therapies news and features for those working in and with pharma, biotech and healthcare.

New centre aims to Catapult UK into cell and gene therapy lead

New centre aims to Catapult UK into cell and gene therapy lead

Also working on the site is contract research specialist Thermo Fisher Scientific, helping to create an ecosystem of cell and gene therapy expertise. ... To address the clinical barriers to adopting these entirely novel cell and gene therapies, the

Latest news

  • GSK hands rare disease assets over to Orchard GSK hands rare disease assets over to Orchard

    gene and cell therapies, including University College London; Great Ormond Street Hospital; the University of Manchester; the University of California Los Angeles; and Boston Children’s Hospital. ... GSK isn’t exiting cell and gene therapy entirely,

  • Is acquisitive Celgene now eyeing CAR-T specialist Juno? Is acquisitive Celgene now eyeing CAR-T specialist Juno?

    That alliance covers chimeric antigen receptor T cell (CAR-T) therapies, including Juno’s lead candidate JCAR017 which is in the final stages of development and could get its first approvals ... medicinal products such as cell and gene therapies.

  • New NHS Alliance launches healthcare TV programme New NHS Alliance launches healthcare TV programme

    Presented by newsreader Natasha Kaplinksy, the news-style piece will combine key interviews, case studies and sponsored stories from Bristol-Myers Squibb, Cell &Gene Therapy Catapult, and Novartis to name a ... disease cures and innovative cell and gene

  • Novartis claims first CAR-T approval, setting $475k price tag Novartis claims first CAR-T approval, setting $475k price tag

    FDA commissioner Scott Gottlieb said the approval ushers in “a new frontier in medical innovation”, adding: “New technologies such as gene and cell therapies hold out the potential to transform medicine ... The agency has approved Kymriah for

  • UK life sciences sector sets out its post-Brexit growth proposals UK life sciences sector sets out its post-Brexit growth proposals

    £30m for three new sites for the Advanced Therapies Treatment Centre, tasking them with establishing a network of hospital-based centres for developing and delivering cell and gene therapies. ... £12m to expand the Cell and Gene Therapy Manufacturing

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    Cell and gene therapies in particular are heralding remarkable curative medicines, which are given only once, or over the short term. ... And it is a revolution. that is happening right now; there are many such therapies in company pipelines, several of

  • The good, the bad and the ugly The good, the bad and the ugly

    Merck’s success in oncology will likely continue, driven by Keytruda’s lead in the frontline non-small cell lung cancer setting, ”says Cai Xuan, senior analyst, oncology and haematology, GlobalData. ... It will also be interesting to see how gene

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    This hypothetical evaluation highlights that, while certain parameters may be relaxed for cell and gene therapies, the established requirements for safety, efficacy and cost-effectiveness will still apply. ... Manufacturers of cell and gene therapies

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    Ultimately, the hope is that therapies can be found that, aside from relieving the pressure on the heart, can actually stop or reverse disease progression - and gene and stem cell therapies ... The aim of the stem cell therapies is to populate damaged

  • Anticipating the future in healthcare Anticipating the future in healthcare

    Gene therapies have been shown to heal genetic disorders through a single series of interventions, while cell therapies that can replace destroyed functional tissue are having a significant impact on how ... Pioneering new technology. Case study:

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Avita Medical appoints CEO Avita Medical appoints CEO

    chief scientific officer, global business development and licensing, and chief scientific officer for its cell and gene therapy unit. ... and gene therapies for Novartis subsidiaries Systemix Inc.

  • Paul Blake joins Oxford BioMedica Paul Blake joins Oxford BioMedica

    Paul Blake joins Oxford BioMedica. He will lead the development of pipeline of gene and cell therapies. ... He will head the clinical development of the company's pipeline of gene and cell therapies.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Life at the end of the Brexit tunnel

    An Advanced Therapies Treatment Centre to develop cell and gene therapies. ... Expansion of the Cell and Gene Therapy Manufacturing Centre in Stevenage.

  • Introduction to the manufacturing of biologics

    However, the broad definition of a biologic is they are created by either a microorganism or a mammalian cell, and are large, complex molecules; the majority of which are proteins ... include blood or blood products, gene therapies, vaccines, and cell

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics